Why growth stock Fevertree Drinks plc could still be a buying opportunity

Fevertree Drinks plc (LON:FEVR) could still deliver big gains, argues Roland Head.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investors watching premium mixer group Fevertree Drinks (LSE: FEVR) will have noticed a sharp rise in the shares last week. And although I usually take a cautious view on highly-rated growth stocks, I have to admit I can see why the market might be getting excited following the recent news.

A much bigger market

Fevertree’s success has been remarkable although, so far, it’s mostly been restricted to the UK. However, the company now appears to be gearing up for a full-scale assault on the US market.

Back in December, the firm gave notice to its US distributor and appointed a North America CEO, Charles Gibb, who will take charge of selling directly into this potentially huge market. Management hope that mixers, such as cola and ginger ale, will find favour in a market where gin & tonic isn’t quite as popular as it is in the UK.

Profits could rocket

As my colleague Rupert Hargreaves recently observed, rumours are circulating that Fevertree might also have become a takeover target for Unilever. This could result in a big payday for shareholders.

But what interests me even more is the profit potential that’s built into the company’s business model. By outsourcing production, Fevertree has avoided the need to invest in big factories and other costly assets.

Taking this approach means that fixed costs are low and the group can enjoy rising profits, without having to scale up its own spending. The impact is clear, with operating margins having risen from 23% in 2014 to 33.6% last year. Strong cash generation has also left the group with net cash of £40m.

A word of warning

Of course, Fevertree could flop in the US and a takeover bid might not materialise. If this happens — or if growth slows in the UK — the group’s shares could fall sharply and a forecast P/E of 62 doesn’t leave much room for error.

Despite this, I think the risks are worth taking. This is a stock I’d continue to hold.

Another growth star

Fevertree isn’t the only growth stock that’s caught my eye. Catering firm SSP Group (LSE: SSPG) has risen by 137% over the last three years. The group, which operates restaurants and cafes in travel locations such as airports, has also seen profits rise 74% since 2015.

Management credibility is high following several successful years. It’s worth remembering that chief executive Kate Swann’s previous role was at WH Smith, where she masterminded the retailer’s successful expansion into the travel sector.

New year has “started well”

In a trading statement issued today, SSP says its financial year has “started well”, with revenue growth of 12.2% during the first quarter. The gains include like-for-like sales growth of 2.7%, and net contract gains of 8.1%.

These figures suggest to me that the group’s existing outlets are performing well and that it’s winning attractive levels of new business.

Although SSP shares trade on a fairly demanding 2018 forecast P/E of 29, I believe the group’s steady growth and strong financial performance could justify this price tag. Earnings are expected to rise by 14% this year, and the tone of today’s Q1 statement sounded very positive to me.

I wouldn’t be surprised if the firm upgraded its guidance as the year unfolds. I’d continue to hold.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no positions in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended Unilever. The Motley Fool UK owns shares of SSP Group. The Motley Fool UK has recommended WH Smith. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Number three written on white chat bubble on blue background
Investing Articles

Just released: the 3 best growth-focused stocks to consider buying in May [PREMIUM PICKS]

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

With £1,000 to invest, should I buy growth stocks or income shares?

Dividend shares are a great source of passive income, but how close to retirement, should investors think about shifting away…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Warren Buffett should buy this flagging FTSE 100 firm!

After giving $50bn to charity, Warren Buffett still has a $132bn fortune. Also, his company has $168bn to spend, so…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing For Beginners

I wish I’d known about this lucrative style of stock market investing 20 years ago

Research has shown that over the long term, this style of investing can generate returns in excess of those provided…

Read more »

Woman using laptop and working from home
Investing Articles

Is this growing UK fintech one of the best shares to buy now?

With revenues growing at 24% and income growing at 36%, Wise looks like one of the best shares to buy…

Read more »

Dividend Shares

Are Aviva shares one of the UK’s best investments today?

UK investors have been piling into Aviva shares recently. However, Edward Sheldon's wondering if he could get bigger returns elsewhere.

Read more »

Older couple walking in park
Investing Articles

10.2% dividend yield! 2 value shares to consider for a £1,530 passive income

Royston Wild explains why investing in these value shares could provide investors with significant passive income for years to come.

Read more »

man in shirt using computer and smiling while working in the office
Investing Articles

Nvidia and a FTSE 100 fund own a 10% stake in this $8 artificial intelligence (AI) stock

Ben McPoland explores Recursion Pharmaceuticals (NASDAQ:RXRX), an up-and-coming AI firm held by Cathie Wood, Nvidia and one FTSE 100 trust.

Read more »